These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38613685)

  • 1. Leveraging meta-regression to test if medication effects on cue-induced craving are associated with clinical efficacy.
    Nieto SJ; Du H; Meredith LR; Donato S; Magill M; Ray LA
    Psychopharmacology (Berl); 2024 Aug; 241(8):1679-1689. PubMed ID: 38613685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study.
    Ray LA; Nieto SJ; Meredith LR; Burnette E; Donato S; Magill M; Du H
    Psychopharmacology (Berl); 2023 Sep; 240(9):1921-1930. PubMed ID: 37452887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder.
    Ray LA; Du H; Green R; Roche DJO; Bujarski S
    Neuropsychopharmacology; 2021 Feb; 46(3):519-527. PubMed ID: 33235284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology.
    Meredith LR; Burnette EM; Nieto SJ; Du H; Donato S; Grodin EN; Green R; Magill M; Baskerville WA; Ray LA
    Alcohol Clin Exp Res (Hoboken); 2023 Sep; 47(9):1629-1645. PubMed ID: 37423771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
    Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
    Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of varenicline on alcohol cue reactivity in heavy drinkers.
    Roberts W; Harrison ELR; McKee SA
    Psychopharmacology (Berl); 2017 Sep; 234(18):2737-2745. PubMed ID: 28600734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing alcohol cue reactive and non-reactive individuals with alcohol use disorder.
    Kirsch DE; Grodin EN; Ray LA
    Addict Behav; 2024 Aug; 155():108028. PubMed ID: 38640885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.
    Karl D; Bumb JM; Bach P; Dinter C; Koopmann A; Hermann D; Mann K; Kiefer F; Vollstädt-Klein S
    Psychopharmacology (Berl); 2021 Aug; 238(8):2179-2189. PubMed ID: 33846866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
    Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
    Psychopharmacology (Berl); 2014 Sep; 231(18):3799-807. PubMed ID: 24647921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural Correlates of Stress and Alcohol Cue-Induced Alcohol Craving and of Future Heavy Drinking: Evidence of Sex Differences.
    Radoman M; Fogelman N; Lacadie C; Seo D; Sinha R
    Am J Psychiatry; 2024 May; 181(5):412-422. PubMed ID: 38706332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel human laboratory model for screening medications for alcohol use disorder.
    Ho D; Towns B; Grodin EN; Ray LA
    Trials; 2020 Nov; 21(1):947. PubMed ID: 33225963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-regression of methodological features that predict the effects of medications on the subjective response to alcohol.
    Green R; Du H; Grodin EN; Nieto SJ; Bujarski S; Roche DJO; Ray LA
    Alcohol Clin Exp Res; 2021 Jul; 45(7):1336-1347. PubMed ID: 34120356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial.
    Burnette EM; Baskerville WA; Grodin EN; Ray LA
    Trials; 2020 Sep; 21(1):779. PubMed ID: 32912290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder.
    Venegas A; Ray LA
    Am J Drug Alcohol Abuse; 2020; 46(1):131-138. PubMed ID: 31295037
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.
    Hendershot CS; Wardell JD; Samokhvalov AV; Rehm J
    Addict Biol; 2017 Nov; 22(6):1515-1527. PubMed ID: 27411969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial.
    Wetherill RR; Spilka N; Jagannathan K; Morris P; Romer D; Pond T; Lynch KG; Franklin TR; Kranzler HR
    Neuropsychopharmacology; 2021 Jul; 46(8):1414-1420. PubMed ID: 33558678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cue reactivity and its relation to craving and relapse in alcohol dependence: a combined laboratory and field study.
    Witteman J; Post H; Tarvainen M; de Bruijn A; Perna Ede S; Ramaekers JG; Wiers RW
    Psychopharmacology (Berl); 2015 Oct; 232(20):3685-96. PubMed ID: 26257163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baclofen for alcohol use disorder.
    Minozzi S; Saulle R; Rösner S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012557. PubMed ID: 30484285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of leptin and ghrelin on neural cue-reactivity in alcohol addiction: Two streams merge to one river?
    Bach P; Bumb JM; Schuster R; Vollstädt-Klein S; Reinhard I; Rietschel M; Witt SH; Wiedemann K; Kiefer F; Koopmann A
    Psychoneuroendocrinology; 2019 Feb; 100():1-9. PubMed ID: 30268001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial.
    Miranda R; Ray L; Blanchard A; Reynolds EK; Monti PM; Chun T; Justus A; Swift RM; Tidey J; Gwaltney CJ; Ramirez J
    Addict Biol; 2014 Sep; 19(5):941-54. PubMed ID: 23489253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.